retatrutide when will it be available ๐๏ธ NEW EPISODE: RetatrutideโThe Triple Agonist *Not licensed* this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide for Weight Loss: TRIUMPH-1
Description
Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients

Drug Approvals & Launches 1 min read China approves Pfizer GLP-1 drug for weight management In February, Pfizer licensed the mainland China commercialisation rights for Xianweiying, also known as ecnoglutide, from Sciwind, based in the eastern city of Hangzhou

They also establish shelf life and proper storage requirements

Custom dosages supported

The answer is straightforward
One thing to consider is that most insurance plans do not cover GLP-1 medications for weight loss, and these medications can be very expensive
